Clinical trial
Effect of Antiseizure Medications on Complete Blood Count Parameters Among Egyptian Children With Epilepsy
NCT07883980 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Antiseizure Medications on Complete Blood Count Parameters Among Egyptian Children With Epilepsy
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 20, 2026
- Completion date
- March 1, 2028
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 1 arm.
-
Children with Epilepsy on Antiseizure Medications
Newly diagnosed children with epilepsy who will receive antiseizure medications and undergo serial complete blood count assessments.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in platelet count
Mean change in platelet count from baseline after initiation of antiseizure medication.
Lead sponsor's other trials
Assiut University, most recent start first.
+5,075 more trials See the organization page
Similar trials
Same condition (Epilepsy) and phase, most recent start first.
+534 more trials See the condition page